Hereditary Cancer Panel

About Oxford Nanopore

Oxford Nanopore's mission is to enable the analysis of any living thing, by anyone, anywhere. The company has successfully transitioned from an academic spin-out to a publicly listed leader, disrupting the genomics industry with its unique long-read, real-time sequencing platform. Its strategy focuses on expanding from research use into regulated clinical diagnostics, biopharma, and applied markets by leveraging the inherent advantages of its scalable technology and end-to-end workflows.

Therapeutic Areas

Other Hereditary Cancer Risk Drugs